Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented Product Type (Combined Nutritional Supplements, Single Nutritional Supplements), By Indication (Perimenopause, PMS), By Formulation (Capsules/Tablets, Powder, Softgels, Other), By End Use (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 21.45 Billion
CAGR (2026-2031)	5.56%
Fastest Growing Segment	PMS (Premenstrual Syndrome)
Largest Market	North America
Market Size (2031)	USD 29.68 Billion

Market Overview

The Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market will grow from USD 21.45 Billion in 2025 to USD 29.68 Billion by 2031 at a 5.56% CAGR. Premenstrual Syndrome (PMS) and menstrual health supplements are specialized nutraceutical formulations, comprising vitamins, minerals, and botanical extracts, designed to mitigate the physiological and psychological symptoms associated with the menstrual cycle. The market is primarily supported by the rising global prevalence of premenstrual disorders and a fundamental consumer shift toward preventive, non-pharmaceutical health management. Unlike temporary market trends such as novel delivery formats, these drivers reflect a structural prioritization of long-term reproductive wellness and a sustained demand for natural alternatives to conventional pain medication.

A significant challenge impeding broader market scalability is the complex regulatory landscape, where varying standards for health claim substantiation restrict manufacturers from communicating specific therapeutic benefits without extensive clinical validation. This lack of global harmonization often complicates product distribution and marketing compliance. Highlighting the growing reliance on specific symptom-targeting ingredients, according to the Council for Responsible Nutrition, in 2024, the usage of magnesium, a vital nutrient utilized for managing menstrual cramps and mood fluctuations, rose to 23 percent among supplement users.

Key Market Drivers

Increasing consumer awareness and the destigmatization of menstrual health are fundamentally reshaping market dynamics by encouraging open dialogue about symptoms that were previously normalized or ignored. This cultural shift has transitioned menstrual care from basic hygiene to comprehensive management, prompting women to actively seek nutraceutical interventions for maintaining productivity and well-being. The market is witnessing a direct correlation between this heightened literacy and product consumption, as consumers move beyond general wellness products to targeted solutions. According to The Vitamin Shoppe, June 2024, in the 'Health & Wellness Trend Report 2024', sales of specialized PMS formulas increased by 12 percent over the previous year, highlighting the growing consumer demand for symptom-specific management.

Concurrently, a rising preference for natural, organic, and plant-based ingredients is driving the formulation of clean-label supplements as consumers retreat from synthetic pharmaceuticals. This trend favors botanical extracts and bioavailable minerals perceived as safer for long-term use in regulating hormonal fluctuations compared to conventional pain medication. According to Holland & Barrett, November 2024, in the 'Wellness Trends Report 2025', online searches for Magnesium Glycinate, a key mineral form favored for its gentle absorption and muscle-relaxing properties during menstruation, increased by 180 percent. This demand for high-quality, non-pharmacological options is supporting broader category growth; according to Haleon, February 2025, in the '2024 Full year results', organic revenue for the Vitamins, Minerals and Supplements division grew by 7.6 percent, underscoring the sector's sustained financial expansion.

Download Free Sample Report

Key Market Challenges

The complex regulatory landscape and varying standards for health claim substantiation present a formidable barrier to the scalability of the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. Because regulations regarding dietary supplements differ significantly across regions, manufacturers face substantial difficulties in standardizing product formulations and marketing messages. In many jurisdictions, companies are legally restricted from making specific therapeutic claims—such as explicitly stating a product relieves menstrual cramps or mitigates hormonal mood swings—without extensive and costly clinical validation. This limitation restricts brands from effectively communicating the full efficacy of their botanical and nutrient-based formulations to consumers, thereby dampening potential sales volume and market penetration.

This regulatory bottleneck is particularly impactful given the rising consumer interest in specialized functional ingredients. According to the Council for Responsible Nutrition, in 2024, the usage of ashwagandha, a botanical extract increasingly incorporated into formulations for stress and mood regulation, reached 8 percent among supplement users. While consumer demand for such natural alternatives is evident, the inability of manufacturers to explicitly label these products with their direct PMS-related benefits due to strict substantiation requirements limits product differentiation. Consequently, the market struggles to convert this growing ingredient awareness into broader category growth, as consumers remain hesitant to purchase products that often carry vague or diluted health claims.

Key Market Trends

The mainstreaming of cycle-syncing supplement regimens is fundamentally altering product development, as consumers increasingly reject static multivitamins in favor of phase-specific formulations tailored to the follicular, ovulatory, luteal, and menstrual phases. This trend transcends basic nutrient replenishment, driving demand for sophisticated 28-day kits that align ingredient release profiles—such as boosting magnesium during the luteal phase for mood regulation or increasing iron during menstruation—with real-time hormonal fluctuations. This shift from reactive symptom treatment to proactive hormonal optimization is evidenced by surging digital engagement. According to The Drum, January 2025, in the article 'Why are women forced to turn to TikTok for menstrual advice? Where are the brands?', Google Trends data reveals that consumer interest in cycle syncing increased by 124 percent year-on-year, signaling a massive untapped opportunity for brands to educate and capture this knowledgeable demographic.

Simultaneously, the integration of AI-driven personalized nutrition plans is reshaping business models by converting sporadic purchasers into long-term subscribers through data-backed customization. By utilizing algorithmic quizzes that analyze individual symptom patterns and biometric data, manufacturers are now able to curate high-precision daily packs that address specific reproductive health goals, such as perimenopausal transition or PMS severity, thereby enhancing perceived value and retention. This technological convergence is delivering tangible financial results for major industry players. According to NutraIngredients, July 2024, in the article 'Unilever talks explosive growth of its wellness business', the incorporation of emerging tools like artificial intelligence alongside a strategic focus on women's health categories contributed to the 20 percent underlying sales growth of the company's Health & Wellbeing Collective.

Segmental Insights

The Premenstrual Syndrome segment represents the fastest-growing category within the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market. This accelerated expansion is largely attributed to a rising consumer preference for natural and botanical alternatives over conventional synthetic pharmaceuticals for managing monthly symptoms. Increasing health literacy regarding hormonal fluctuations has prompted individuals to seek specialized nutritional solutions that address physical and emotional distress during the luteal phase. As a result, the widespread adoption of targeted dietary interventions to mitigate discomfort is fueling the substantial demand for PMS-specific supplement formulations.

Regional Insights

North America maintains the leading position in the Global Premenstrual Syndrome and Menstrual Health Supplements Market, driven by widespread consumer awareness regarding women’s wellness and preventative care. The region benefits from a strong retail infrastructure and high disposable income, which supports consistent expenditure on dietary management products. Furthermore, the market is stabilized by the regulatory oversight of the U.S. Food and Drug Administration, which enforces standards for dietary supplements and fosters consumer confidence. The presence of key industry players within the United States and Canada further ensures high product availability and market penetration.

Recent Developments

• In August 2025, Fairhaven Health announced a significant expansion of its product portfolio to address women's health needs beyond its traditional fertility focus. The company introduced a new line of supplements tailored to various life stages, including specific formulations for menstrual cycle regularity and menopause relief. This strategic shift involved the development of clean-label, hormone-free products supported by clinical research to ensure efficacy for cycle management and hormonal health. The initiative aimed to serve a broader demographic by providing science-backed nutritional support for women experiencing symptoms related to menstruation, hormonal transitions, and overall reproductive well-being.
• In November 2024, the United Kingdom-based brand Ova officially launched its operations with a suite of supplements targeting egg health and hormonal balance. The company introduced a product specifically formulated for advanced hormonal support, designed to assist individuals dealing with irregular cycles or conditions such as polycystic ovary syndrome and endometriosis. This supplement featured a unique blend of nutrients intended to regulate menstrual health and improve reproductive outcomes. The launch secured distribution through major national retail chains, positioning the company as a comprehensive provider of scientifically formulated solutions for menstrual regulation and fertility preservation.
• In August 2024, Intimina, a brand recognized for its intimate health devices, diversified its offerings by launching a new range of hormone-support supplements. The company introduced a formulation titled "Balance," which utilized B vitamins and red clover to actively support hormonal regulation and overall reproductive health. Alongside this, a second supplement named "Clear" was released, featuring D-mannose and cranberry extract to promote urinary tract health. These additions were developed to complement the company's existing menstrual care products, reflecting a growing industry trend towards providing holistic, ingestible solutions for the management of menstrual and hormonal well-being.
• In May 2024, Bayer expanded its Midol brand into the dietary supplement category with the introduction of a new product designed to address premenstrual symptoms. The company launched "Peace Out PMS," a drug-free supplement formulated with chasteberry extract to alleviate common cycle-related discomforts such as bloating, breast tenderness, and mild mood fluctuations. This strategic move marked the brand's first venture beyond traditional over-the-counter pain relief medication, aiming to provide hormone-free support for menstrual wellness. The release broadened the company's portfolio in the women's health sector, offering consumers accessible, non-pharmaceutical options for managing monthly cycle symptoms.

Key Market Players

• Herbalife International of America, Inc.
• Nature’s Bounty
• Amway Corp.
• GNC Holdings, LLC
• USANA Health Sciences, Inc
• GlaxoSmithKline Plc
• MetP Pharma AG
• Archer-Daniels-Midland Company
• Power Gummies
• Looni

By Indication	By Formulation	By End Use	By Region
Perimenopause PMS	Capsules/Tablets Powder Softgels Other	Pharmacies/Drug Stores Online Sales Channel Direct Sales Channel Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market , By Indication:

• Perimenopause
• PMS

• Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market , By Formulation:

• Capsules/Tablets
• Powder
• Softgels
• Other

• Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market , By End Use:

• Pharmacies/Drug Stores
• Online Sales Channel
• Direct Sales Channel
• Others

• Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE